Annex

United Kingdom

In point 1.2.4 of Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed) to Regulation (EEC) No 2377/90 the following entry for ‘Gamithromycin’ is inserted after erythromycin:

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
‘Gamithromycin Gamithromycin Bovine 20 μg/kg Fat Not for use in animals producing milk for human consumption.’
200 μg/kg Liver
100 μg/kg Kidney

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
‘Gamithromycin	Gamithromycin	Bovine	20 μg/kg	Fat	Not for use in animals producing milk for human consumption.’
			200 μg/kg	Liver
			100 μg/kg	Kidney